Responding to Industry Initiatives to Increase Access to Medicines and Other Health Technologies in Countries. EMP Policy Brief Series No. 2.0
(2017; 8 pages) [French]

Resumen

In recent years, there has been an increase in the number and scope of activities carried out by pharmaceutical and medical device companies to facilitate access to medicines and other health technologies and strengthen health systems in low- and middle-income countries. These initiatives follow a call for more commitment from the private and public sectors to contribute to Universal Health Coverage.

Despite the proliferation of these initiatives, no global framework or guidelines exist to guide governments in their development, implementation and regulation. Thus, the challenges for governments working with industry are: 1) ensuring public accountability; 2) sharing and managing risks; 3) monitoring and evaluating performance; 4) ensuring good governance; and 5) long-term sustainability.

This policy brief was therefore designed for governments to highlight potential risks and benefits of these initiatives and to provide guidance to effectively respond to industry initiatives related to medicines and other health products.

 
El Portal de Información - Medicamentos Esenciales y Productos de Salud de la OMS fue diseñado y es mantenido por la ONG Human Info. Última actualización: le 1 diciembre 2019